{"id":96147,"date":"2026-04-14T10:32:29","date_gmt":"2026-04-14T07:32:29","guid":{"rendered":"https:\/\/u1f987.com\/en\/?p=96147"},"modified":"2026-04-14T10:53:11","modified_gmt":"2026-04-14T07:53:11","slug":"novo-nordisk-to-integrate-openai-technology-for-drug-development","status":"publish","type":"post","link":"https:\/\/u1f987.com\/en\/novo-nordisk-to-integrate-openai-technology-for-drug-development\/","title":{"rendered":"Novo Nordisk to Integrate OpenAI Technology for Drug Development"},"content":{"rendered":"<p>Novo Nordisk A\/S plans to implement OpenAI&#8217;s AI technologies across all its divisions to accelerate drug development, according to <a href=\"https:\/\/www.bloomberg.com\/news\/articles\/2026-04-14\/novo-taps-openai-to-speed-development-of-new-obesity-drugs?srnd=phx-ai\">Bloomberg<\/a>.<\/p>\n<p>The Danish manufacturer has not disclosed the financial terms of the partnership. This collaboration will complement Novo&#8217;s existing AI initiatives, including an agreement with Nvidia aimed at scientific research.<\/p>\n<p>The company aims to expedite all processes\u2014from drug development to production planning\u2014as it seeks to regain its position in the competitive obesity treatment market.<\/p>\n<p>Novo was the first to market powerful treatments but has since lost its leadership to American competitor Eli Lilly &#038; Co.<\/p>\n<p>CEO Mike Doustdar emphasized that the deal with OpenAI is not intended to replace scientists or staff. The integration of AI is expected to significantly enhance their efficiency.<\/p>\n<p>Artificial intelligence will assist in faster identification of drug targets, conducting more effective clinical trials, and obtaining clear results from the company&#8217;s data sets.<\/p>\n<p>Doustdar compared the integration of AI to the transition from using faxes to email.<\/p>\n<p>Since his appointment as CEO in August 2025, the entrepreneur has laid off about 9,000 people and reorganized the workforce. He described the changes as a &#8220;culture of performance&#8221; that offers quicker decision-making.<\/p>\n<p>Previously, Novo employees already had access to a special version of OpenAI&#8217;s ChatGPT. The new partnership expands this experience.<\/p>\n<p>Pilot tests will begin in research and development, manufacturing, and commercial divisions. Full integration is expected by the end of 2026.<\/p>\n<p>In June 2025, artificial intelligence <a href=\"https:\/\/u1f987.com\/en\/news\/ai-breakthrough-in-treating-incurable-lung-disease\">created<\/a> a drug for an incurable lung disease.\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novo Nordisk A\/S plans to implement OpenAI&#8217;s AI technologies across all its divisions to accelerate drug development.<\/p>\n","protected":false},"author":1,"featured_media":26216,"comment_status":"open","ping_status":"open","sticky":true,"template":"","format":"standard","meta":{"select":"1","news_style_id":"1","cryptorium_level":"","_short_excerpt_text":"Novo Nordisk to use OpenAI's AI to speed up drug development.","creation_source":"","_metatest_mainpost_news_update":false,"footnotes":""},"categories":[3],"tags":[438,1414],"class_list":["post-96147","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-analysis","tag-artificial-intelligence","tag-medicine"],"aioseo_notices":[],"amp_enabled":true,"views":"32","promo_type":"1","layout_type":"1","short_excerpt":"Novo Nordisk to use OpenAI's AI to speed up drug development.","is_update":"","_links":{"self":[{"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/posts\/96147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/comments?post=96147"}],"version-history":[{"count":1,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/posts\/96147\/revisions"}],"predecessor-version":[{"id":96148,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/posts\/96147\/revisions\/96148"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/media\/26216"}],"wp:attachment":[{"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/media?parent=96147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/categories?post=96147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/u1f987.com\/en\/wp-json\/wp\/v2\/tags?post=96147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}